Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus (Rapamune) versus continued calcineurin inhibitor in heart transplant patients
2005-001183-31Phase 4Completed
- Sponsor
- Roche
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sirolimus in post-orthotopic heart transplantation status (2 arms), sponsored by Roche. Primary endpoint: Renal function change at 24 months post transplant. Started Sep 2005; status: completed.
02
Drugs
sirolimus
03
Conditions
post-orthotopic heart transplantation status
Beyond the preview
Go deeper on 2005-001183-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001183-31.